📈 Market Overview
The global Infection Control Market, valued at USD 54.32 billion in 2024, reached USD 57.31 billion in 2025 and is projected to surge at a CAGR of 6.3% from 2025 to 2030, attaining a valuation of USD 77.67 billion by the end of the period.
Market growth is primarily driven by the rising prevalence of healthcare-associated infections (HAIs), increasing surgical volumes, and advancements in sterilization and disinfection technologies. The growing emphasis on food safety and contamination prevention, coupled with outsourcing of infection control services by hospitals and pharmaceutical manufacturers, continues to reshape this vital healthcare sector.
🔗 Download PDF Brochure
🔍 Browse in-depth TOC on “Infection Control Market”
📊 635 Tables • 59 Figures • 616 Pages
Market Dynamics
Key Growth Drivers
- Increasing incidence of hospital-acquired infections (HAIs) demanding robust sterilization protocols
- Rapid rise in surgical and invasive medical procedures globally
- Continuous innovation in sterilization equipment and reprocessing technologies
- Expanding outsourced sterilization and disinfection services
- Growing awareness of hygiene and safety in food and pharmaceutical manufacturing
These drivers collectively strengthen infection control measures across hospitals, laboratories, and life science industries.
By Treatment Type
The infection control market is segmented into:
- Sterilization Products & Services
- Cleaning & Disinfection Products
- Protective Barriers
- Endoscope Reprocessing Products
- Other Infection Control Solutions
Cleaning & Disinfection Products dominated the market in 2024. They play a crucial role in breaking the chain of infection by eliminating harmful microorganisms from surfaces and equipment. Their routine use in hospitals, pharma facilities, and public institutions positions them as the most widely adopted infection control solution. Moreover, they help healthcare organizations meet regulatory standards while ensuring patient and staff safety.
By End User
The market primarily serves:
- Hospitals & Clinics
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Food & Beverage Industry
- Other End Users
Hospitals remain the largest end-user segment, driven by the surge in nosocomial infections, sterile surgical environments, and strict infection prevention mandates worldwide.
By Region
The market is geographically segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries.
North America Leads the Market
North America captured the largest share of the infection control market in 2024 and is projected to retain its dominance.
- High healthcare spending and strong regulatory oversight
- Early adoption of advanced disinfection and sterilization technologies
- Robust presence of key global players
- Federal initiatives (e.g., CDC, NIH) supporting infection prevention
These factors establish North America as the benchmark region for innovation and compliance in infection prevention and control.
Competitive Landscape
The Infection Control Market is moderately consolidated, with leading players focusing on product innovation, mergers, and strategic collaborations to strengthen their global reach.
Key Players
- STERIS (US)
- Reckitt Benckiser Group plc (UK)
- Fortive (US)
- Sotera Health (US)
- Solventum (US)
- Getinge AB (Sweden)
- Ecolab Inc. (US)
- Olympus Corporation (Japan)
- Envista (US)
- PAUL HARTMANN AG (Germany)
Company Insights
STERIS (US)
A global leader in infection prevention, STERIS offers comprehensive sterilization and decontamination solutions — from steam and low-temperature sterilizers to endoscope reprocessors and cleaning chemicals. The company’s contract sterilization services and strategic acquisitions bolster its dominance across healthcare and life sciences applications.
Reckitt Benckiser Group plc (UK)
Renowned for brands like Dettol and Lysol, Reckitt Benckiser remains a top force in consumer and professional hygiene solutions. The company is expanding its B2B channels, introducing next-generation germ protection products, and reinforcing its role in global infection prevention — particularly during public health crises such as COVID-19.
Request Sample Pages
💡 For more information or customization inquiries, contact MarketsandMarkets.
